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Initial studies
n 1981,Kripke
1 exposed seven nonseasonally
depressed patients to bright white light shortly before
their usual time of arising. Depression scores were
reduced on the following day.In a subsequent study,
2 5
new subjects were added,for a total of 12 subjects,includ-
ing 11 males with major depressive disorder (MDD) (3
with bipolar illness) according to research diagnostic cri-
teria (RDC),
3 who were on an inpatient psychiatric
research ward.In counterbalanced order,the investiga-
tors administered either bright white light (1000 to 2000
lux) or dim red light (less than 25 lux) for 1 h,2 h before
the subject’s usual time of arising.The bright white light
treatment produced significantly lower depression scores
on both the Hamilton
4 and Beck
5 ratings as compared
with baseline. A follow-up pilot experiment of 12
depressed inpatients
6 showed that there was no indica-
tion that 1 h awakening with exposure to dim red light
(25 lux) had any antidepressant effect.
After demonstrating that sunlight and bright artificial
light could suppress human melatonin secretion,Lewy et
al
7 reported on a patient with a bipolar II seasonal mood
cycle whose winter depression remitted when his hours
of daylight were lengthened with bright fluorescent light
(Vital-Lite) of 2000 lux between his time of awakening
(6.00 AM) and 9.00 AM,and between 4.00 PM and 7.00 PM,
thereby extending his daylength (photoperiod) to 13 h (a
spring photoperiod).During light exposure,melatonin
levels declined by 88% between 1.00 and 5.00 AM.
Winter depression has been found to improve when
patients are exposed to bright full-spectrum light before
dawn and after dusk, thereby extending the photope-
riod.
8,9 Bright light consisted of 2500 lux of full-spectrum
light;dim light was 300 lux.Light was administered from
5.00 AM to 8.00 AM, and 5.30 PM to 8.30 PM every day.
Bright light had a marked antidepressant effect,whereas
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In 1981, seven patients with nonseasonal depression were
treated with bright white light. In 1982, bright artificial
light was used to treat a manic-depressive patient with a
seasonal mood cycle. In the last 20 years, a plethora of
studies have further defined the depressive populations,
who are responsive to light treatment; the optimal tim-
ing, intensity, spectral frequency, and duration of treat-
ment; its comparison with other pharmacological inter-
ventions; predictors of response; side-effect profiles; viable
placebo-control conditions; alternative devices and forms
of administration; potential mechanisms and anatomical
pathways mediating light’s physiological effects; and its
application to other disorders and subsyndromal states.
These studies have been conducted across multiple coun-
tries with surprisingly consistent results. Further work is
needed, as highlighted in this review, to clarify the specific
mechanism of action in subtypes of depressive disorders
and differential age and gender effects. Although the
majority of work in this area is relatively new, it behooves
the reader to remember that Solomon, almost 3000 years
ago, wrote in Ecclesiastes: “Truly the light is sweet and a
pleasant thing it is for the eyes to behold the sun” (11:7).
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dim light did not.The response could not be attributed
to sleep deprivation.
Thus, the initial studies of light treatment appeared
promising,but many questions remained concerning the
optimal timing and intensity of treatment intervention.
Methodological issues
Morning versus evening light
Wehr et al
10 found that time of day and suppression of
melatonin were not critical for antidepressant effects of
phototherapy,indicating that photoperiodic mechanisms
were not mediating the efficacy of therapeutic response.
A review of efficacy using a pooled clustering technique
for light therapy of seasonal affective disorder (SAD)
11
reported that 2500-lux intensity light exposure for 2 h
daily for 1 week resulted in significantly more remissions
when administered in the early morning (53%) than in
the evening (38%) or at midday (32%).All three times
were significantly more effective than dim light controls
(11%).Exposure to morning plus evening light provided
no benefit over morning light alone. In support of the
phase-shift hypothesis for winter depression, two
groups
12,13 found that morning bright light phase-
advanced the dim-light melatonin onset (DLMO) and
was more antidepressant than evening light,which phase-
delayed it. The DLMO generally was delayed in the
patients with winter depression compared with the
healthy control subjects. Avery et al
14 also found that
improvement was significantly greater with morning light
than with evening light in 7 patients with winter depres-
sion treated with 7 days of bright light for 2 h daily.Other
workers,
15-17 however, found that either morning or
evening light therapy improved depressive symptoms in
patients with SAD, suggesting that more practical and
flexible schedules for light therapy are appropriate for
SAD,since time of day is not crucial.As Wirz-Justice and
Anderson noted,
18 prior morning light treatment may
prevent an evening light response,and it may potentiate
responses to subsequent morning light.
Duration of response and treatment
The efficacy of treatment of patients with SAD lasts
longer after withdrawal with bright light (>2000 lux) than
with dim light (<300 lux).
19,20 Labbate et al
21 reported
increased response rates in SAD after 2 weeks rather
than 1 week of light treatment:15% of nonresponders at
week 1 responded after week 2 of treatment.Byerley et
al
22 found that,in 3 patients with SAD treated with 2 h of
morning light exposure,remission of symptoms within
2 to 5 days was sustained during the 2-month treatment
period.With regard to daily duration of treatment,2 h,
but not 0.5 h,morning white light was an effective treat-
ment for SAD.
23 Doghramji et al
24 reported that 2 h of
evening light was as effective as 4 h in SAD.As Wirz-
Justice et al
25 commented,in patients who may be super-
sensitive to light, 1 h of 2500 lux may be the minimum
light exposure necessary to maintain an antidepressant
effect in SAD.
Spectral frequency
Oren et al
26 compared green light and red light, and
found that green light induced greater antidepressant
effects than red light.Stewart et al,
27 however,observed
that white light was more effective than green light in
reducing endogenous symptoms, but not the atypical
symptoms characteristic of winter depression. Other
workers
28 reported that ultraviolet (UV) light reduced
depressive symptoms,but that UV-blocked light reduced
only atypical depressive symptoms. Bielski et al
29
reported that both broad-spectrum fluorescent light and
cool white light were equally effective in reducing SAD
symptoms of depression.Brainard et al
30 found that white
light had greater benefit than red or blue light in SAD.
Levitt et al
31 studied dim versus bright red (light-emitting
diode) light,and found there was no significant differ-
ence in response rates between the two different illumi-
nances of red light for SAD.
Alternative techniques: dawn simulation
Bright (1700 lux) dawn simulation (4.00-6.00 AM) was not
effective in reducing depression scores in seven patients
with winter depression compared with a standard bright
(1700 lux) morning (6.00-8.00 AM) light treatment and
contributed to early morning awakening (EMA).
32 In
comparing a gradual dawn signal with a hypothesized
placebo condition, a rapid dawn signal, Avery et al
33
found that improvement was similar for both treatments,
but that EMA was more common with the gradual dawn
condition.In a follow-up study
34 of 22 patients with win-
ter depression,1 week of treatment with 2-h dawn simu-lation peaking at 250 lux resulted in significantly lower
depression scores than 1 week of treatment with a 30-min
dawn simulation peaking at 0.2 lux.Norden and Avery
35
also demonstrated that a slow dawn (a gradually increas-
ing illuminance over 45 min peaking at 100 lux) was bet-
ter than a rapid dawn (light rapidly increasing over a 4-s
period to 100 lux) in 16 patients with subsyndromal win-
ter depression. In a second controlled study of dawn 
simulation of winter depression,Avery et al
36 showed that 
1.5 h of 250 lux dawn simulation with while light resulted
in lower depression scores than 1.5 h of a 2 lux,red dawn
signal.Linjaerde et al
37 found that symptoms of winter
depression improved 57% with lightbox treatment of
1500 to 2500 lux for 2 h in the morning for 6 days com-
pared with 40% for dawn simulation of 60 to 90 min with
100 to 300 lux for 2 weeks.A controlled study of 95 sub-
jects with SAD
38 found that dawn simulation (1.5-h dawn
signal from 4.30-6.00 AM peaking at 250 lux), but not
bright light treatment (10 000 lux for 30 min from 6.00-
6.30 AM), was associated with greater remission rates
than placebo (dim red light,1.5-h dawn signal from 4.30-
6.00 AM peaking at 0.5 lux).
Light visor
Stewart et al
39 reported that a portable,head-mounted
unit (HMU) was as efficacious as a standard lightbox for
the treatment of winter depression.In a study of 105 sub-
jects across five centers,
40 three intensities of a light visor
(60, 600, and 3500 lux) for 2 weeks had equal antide-
pressant efficacy in SAD.Teicher et al
41 found no signifi-
cant differences in therapeutic response between patients
with SAD who were treated with a dim (30 lux) red light
or a bright (600 lux) white light visor. In a controlled
comparison of a lightbox and a HMU in SAD,
42 there
was no significant difference in response rates between
patients with SAD who received 2 weeks of light versus
patients who received no visible light by an HMU, or
between patients who received the lightbox versus the
HMU.
Summary
The majority of studies support the beneficial effects of
particularly morning light in SAD for 2 h with at least
2500 lux. UV light is not required for response. Dawn
stimulation is an effective alternative,although the light
visor is not.
Clinical phenomenology
Effects of latitude
In Iceland,Magnusson and Kristbjarnarson
43 found that
10 000-lux white light was more effective than 400-lux red
light for 40 min for 8 days for treatment of SAD:patients
who improved most on phototherapy also improved
most during summer. In Norway, Lingjaerde et al
44
reported that patients with SAD, after treatment with
1500-lux white full-spectrum light for 2 h in the morning
for 6 days,had a 48% reduction in symptoms compared
with a 56% reduction of patients receiving light and drug
treatment.Improvement at 1 week was maintained for
the rest of the season.
In a follow-up study of SAD in Switzerland,Graw et al
45
observed that 2 to 5 years after participation in a light ther-
apy trial,64% of the patients had a reduction in the inci-
dence and severity of depressive episodes and the use of
antidepressant drugs.In a study of light therapy for SAD
in adolescents in Iceland,
46 light therapy mildly improved
the ability to concentrate and wake up in the morning in
some students,but did not improve school attendance.
Predictors of response
Lam
47 reported that hypersomnia, hyperphagia, and
younger age predicted morning light therapy response
in winter depression.Terman et al
48 observed that,in 103
subjects with winter depression given light treatment,
responders were characterized by atypical symptoms,
especially hypersomnia, afternoon or evening slump,
reverse diurnal variation (evening worse),and carbohy-
drate craving.Nonresponders were characterized mainly
by melancholic symptoms. A follow-up study of 59
patients with winter SAD at the National Institute of
Mental Health
49 found that 42% remained purely sea-
sonal.The occurrence of nonseasonal depression in 44%
of patients was associated with greater severity of illness
and less responsiveness to light treatment. There is a
greater improvement in mood in summer than with light
treatment in winter in patients with SAD.
50 In meta-
analysis of dose-response relationships of phototherapy
for SAD,
51 no significant effects between strong,
medium,and dim light in reducing atypical symptoms of
depression were found, but light intensity varied posi-
tively with the antidepressant effects for typical symp-
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52 found that response rates were simi-
lar in SAD and subsyndromal SAD with morning bright
light therapy of 5000 lux for 3 weeks. Longer exposure
of 45 to 60 min daily tended to be associated with better
outcome. In examining the effects of light therapy on
suicidal ideation,Lam et al
53 found that 67% of patients
with winter depression were clinical responders:45% of
patients showed a reduction in the suicide item score on
the Structured Interview Guide for the Hamilton
Depression Rating Scale, Seasonal Affective Disorders
Version (SIGH-SAD).
54
Prevention
Meesters et al
55,56 observed that administration of light
treatment at the first signs of a winter depression pre-
vented it from developing into a full-blown depression.
When light exposure was administered at a symptom-
free period at the beginning of autumn,however,it was
not successful in preventing the development of winter
depression.
57 Partonen and Lonnqvist,
58 in contrast, did
find that bright light given well in advance of the emerg-
ing symptoms of winter SAD prevented a depressive
episode.
Effects on hypersomnia
Hypersomnia has been associated with a superior
response to morning light.
59 In an open study design,
Lam et al
60 found that patients with winter depression
who had hypersomnia had greater improvement,partic-
ularly in atypical depression symptoms than patients
with insomnia. Evening subjective sleepiness improves
with morning light, even a short 15-min exposure, in
patients with winter depression.
61
Comparison with antidepressant medication
Wirz-Justice et al
62 described a woman with SAD who,
after remitting within a week in each of 6 separate trials
of light therapy, remitted within 2 weeks of initiating
citalopram, despite the delayed sleep and intermittent
awakening induced with citalopram, but not with light
therapy. Ruhrmann et al
63 found that 70% of 40 SAD
patients treated with bright light (3000 lux 2 h daily)
were responders compared with 65% treated with flu-
oxetine (20 mg daily for 5 weeks). Light treatment
improved depression scores faster,while fluoxetine had
a faster effect on atypical symptoms.In 13 SAD patients,
Ghadirian et al
64 compared light therapy for 2 weeks or
tryptophan for 4 weeks in an open repeated-measures
design.Tryptophan was equally effective to light therapy
in treating SAD,but relapse after withdrawal of trypto-
phan occurred more slowly. Improvement of atypical
depressive symptoms after 1 h of light therapy positively
correlated with improvement after 2 weeks of therapy.
65
Comparison with natural light
Eastman
66 documented that the perceived sunlight expo-
sure in SAD patients in Chicago was twice as much in
summer than in winter:the perceived daylength was 4 to
5 h longer in summer than in winter, with a later per-
ceived dusk contributing more to the lengthening than
an earlier perceived dawn.
Wirz-Justice et al
67 observed that 50% of patients with
SAD remitted after a daily 1-h morning walk outdoors
in natural light,which phase-advanced the onset and/or
offset of salivary melatonin secretion, and decreased
morning cortisol compared with low-dose artificial light,
which did not modify depression self-ratings, or mela-
tonin or cortisol patterns.The effects of bright light treat-
ment (2500 lux) on subsyndromal SAD in the workplace
have been studied,
68 and both morning and afternoon
exposure resulted in similar levels of improvement in
mood,energy,alertness,and productivity.
Side effects
Terman et al
69 reviewed the ocular effects of particularly
the more recent treatment approach of using approxi-
mately 10 000 lux light exposure for 30 min.Although
ophthamological examinations have thus far revealed no
induced abnormalities,precaution is warranted with use
of photosensitizing antidepressant drugs that may
enhance UV– and visible-light–induced lesions. Bauer
et al
70 observed the induction of hypomania in winter
depressives treated with 4 weeks of light treatment.
Seasonality—but not diagnosis of major depression,
bipolar disorder with seasonal pattern, or control sub-
ject—predicted the emergence of manic symptoms.
The influence of comorbid and other disorders
Stewart et al
71 questioned whether SAD and atypical
depression might be subtypes of the same disorder.
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8.00 PM),however,was less effective in treating patients
with atypical depression than with SAD,suggesting that
the two disorders are separate with a different under-
lying pathophysiology. Partonen and Lonnqvist
72
observed that in patients with comorbid personality dis-
order, the remission rate with light treatment was simi-
lar to that of patients with recurrent winter depression,
although there was a more variable course and an
increased risk of an earlier onset of a depressive episode.
A controlled trial in 28 children (aged 7-17 years)
73
investigated the efficacy of light therapy for the treat-
ment of pediatric SAD. In a primary care setting,
74
patients with SAD improved after light therapy, but
bright white versus dim red light was not associated with
greater improvement.
Response to placebo
Eastman et al
75 observed that 32 patients with SAD
responded equally to 1 h of morning light (7000 lux) and
1 h of morning placebo treatment (a deactivated nega-
tive ion generator). Richter et al,
76 comparing exposure
to real bright light and placebo bright light perceived
through hypnosis, concluded that the findings did not
support the hypothesis that the long-term results of light
treatment in SAD were merely placebo effects.Terman
and Terman
77 reported that 58% of patients with SAD
responded to high-density negative ionizer treatment,
whereas 15% responded to low-density ion generator
treatment.A placebo-controlled trial of bright (6000 lux)
morning light, bright evening light, or morning placebo
(a sham negative ion generator) for 1.5 h daily for 4
weeks,
78 found that by using strict response criteria from
the SIGH-SAD
54 (50% decrease of baseline and ≤8),
61% of SAD patients responded to morning light,50%
to evening light,and 32% to placebo;however,there was
no significant benefit on mean Hamilton depression rat-
ing scores.A controlled trial of timed bright light and
negative air ionization (6 groups) in 158 patients with
winter depression,
79 reported that low-density ion
response was inferior to all other groups, that evening
light response was reduced when preceded by treatment
with morning light, and when stringent remission crite-
ria were used, a higher response rate to morning than
evening light.
In summary,SAD patients,in particular,are responsive
to light treatment. Carbohydrate craving and hyper-
somnia are predictors of response.Acute intervention is
more efficacious than prophylactic treatment. Light
administration is as effective as antidepressant treatment
or natural light exposure.Side effects are minimal,with
the exception of the induction of mania in bipolar
patients,and there may be significant placebo effects.
Light treatment of nonseasonal 
mood disorders
Major depressive disorder
In an open trial with unmatched patient groups,
Yerevanian et al
80 found that 1 to 2 weeks of light treat-
ment with ≥2000 lux was effective in reducing depressive
symptoms in seasonal, but not nonseasonal patients,
whose functioning was more impaired (by unpaired 
t tests).Although the patient groups were unmatched,in
a comparison of bright white light (2500 lux) and dim
light (50 lux) from approximately 7.00 to 9.00 AM for 7
days in up to 42 patients who met RDC for nonseasonal
MDD,other workers
81-83 observed a significant reduction
in depressive symptomatology in all patients,but the dif-
ference between bright and dim light was not significant.
In a 10-day study of morning (6.00-8.00 AM) or evening
(6.00-8.00 PM) bright (1500 lux) light room treatment of
90 patients with either seasonal or nonseasonal MDD,
84
patients with seasonal pattern improved significantly
more than those with a nonseasonal pattern,irrespective
of time of treatment,atypical symptoms,or carbohydrate
craving.Yamada et al
85 administered bright or dim light
in the morning or evening to 27 unmedicated patients
with nonseasonal depression by Diagnostic and
Statistical Manual of Mental Disorders, Revised Third
Edition (DSM-III-R)
86 criteria and found that bright,but
not dim, light significantly improved clinical symptoms
of depression,independent of the time of treatment.The
circadian rhythm of body temperature was more sensi-
tive to the entraining effects of bright light in depressed
versus normal control subjects, but was not related to
clinical improvement. In a reassessment of the speed,
efficacy,and combined treatment effects for nonseasonal
depression, Kripke
87 observed that light treatment pro-
duced net benefits in the range of 12% to 35% often
within a week, and that the effects for nonseasonal and
seasonal depression were comparable and produced
faster antidepressant benefits than psychopharmaco-
logical treatment.
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In the setting of a psychiatric hospital,Wirz-Justice et al
88
reported that 61% of 37 nonmedicated patients with
major depression responded to light treatment in a 10-
day open trial using ceiling lights of 3000 lux either for
8 h (5.00-9.00 AM and 4.00-8.00 PM) or 4 h only (5.00-9.00
AM). Results of pilot data using 2 h of 10 000 lux light
also suggested that further controlled trials were war-
ranted in this population. In a controlled trial of hospi-
talized veterans with nonseasonal MDD or depressed
forms of bipolar disorder, Kripke et al
89 found that the
25 patients treated with bright white light (2000-3000
lux) improved in measures of depression compared with
the 26 patients randomized to dim red light placebo-con-
trol treatment.Two patients treated with bright white
light became hypomanic.Partial relapse appeared within
2 days. Patients treated in winter responded as well as
those treated in summer. Beauchemin and Hays
90
observed that in a psychiatric inpatient unit, depressed
patients in sunny rooms had a significantly shorter hos-
pital stay than those in dull rooms.In a follow-up study,
91
they randomly assigned depressed inpatients to high and
low levels of artificial light and found that both unipolar
and bipolar depressed patients responded more to bright
than dim light when used as an adjunct to pharma-
cotherapy.Benedetti et al
92 also found that length of hos-
pitalization for 415 unipolar and 187 bipolar depressed
inpatients was reduced in bipolar patients in eastern
rooms exposed to direct sunlight in the morning com-
pared with western rooms.No effect was found in unipo-
lar inpatients. In a placebo-controlled, crossover study
of bright light treatment of depression in institutional-
ized older adults, Sumaya et al
93 found that 50% of
patients were no longer in the depressed range after 1
week treatment with 10 000 lux, but their depression
scores were unchanged after placebo (300 lux) or con-
trol (no treatment) conditions. Patients with higher
depression scores, associated with longer duration of
institutionalization, experienced the greatest improve-
ment with the 10 000 lux treatment.
Interaction with medication and other antidepressant
treatment
Levitt et al
94 administered a 2-week course of bright light
therapy to 10 patients who presented during the winter
months with major depression and who had failed an
adequate trial of antidepressants,or who had relapsed
following a successful course of antidepressants and
found that augmentation with bright lights resulted in
substantial improvement in 7 of the 10 patients.
Holsboer-Trachsler et al
95 reported that adjunctive treat-
ment with bright light or sleep deprivation did not has-
ten the onset of antidepressant action of the antidepres-
sant trimipramine,but the groups were not balanced on
baseline prognostic factors.Neumeister et al
96 adminis-
tered bright (3000 lux) or dim (100 lux) light for 6 days
to depressed patients from the morning after they under-
went partial sleep deprivation (PSD) treatment. In
responders to PSD, bright light therapy prevented the
relapse after the next night of sleep and significantly pro-
longed the antidepressant effects of PSD up to 7 days.
Patients treated with dim light relapsed after a recovery
night of sleep and showed no further improvement of
their depressive symptoms after 1 week of dim light
treatment.PSD nonresponders did not benefit from light
treatment. Muller et al
97 found that the side effects of
adjunct bright light therapy as compared with antide-
pressant (trimipramine) monotherapy included aggra-
vated sedation,restlessness,sleep disturbance,decreased
appetite,and vertigo.Prasko et al
98 treated inpatients with
recurrent nonseasonal depression with (i) bright light
(5000 lux from 6.00-8.00 AM) and impramine 150 mg/day;
(ii) bright light and placebo;or (iii) dim red light (500 lux
from 6.00-8.00 AM) and imipramine 150 mg/day.Patients
in all 3 groups improved significantly,but the improve-
ment of patients with bright light plus placebo was non-
significantly superior to the other two groups.Loving et
al
99 found that in 13 patients with MDD who underwent
a half night of home wake therapy (sleep deprivation),
those who subsequently received 10 000 lux bright white
light for 30 min between 6.00 and 9.00 AM improved 27%
in 1 week, compared with those receiving dim red
(placebo) light at a comparable time.
Bipolar illness
The effects of 2 weeks of bright light and 1 week of dim
light were investigated in patients with bipolar II SAD
versus controls
100 and bright light was found to reduce or
eliminate all group differences and variability in behav-
ioral engagement,a mood dimension specifically associ-
ated with depression. Papatheodorou and Kutcher
101
treated persistent depressive symptoms in adolescent-
onset bipolar disorder with adjunctive light therapy (10
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marked (70%) decrease in symptoms,2 had a moderate
(40%) decrease, and 2 had mild to no response. In 2
patients with bipolar disorder and 1 with recurrent
MDD,Praschak-Rieder et al
102 observed that within the
first week after beginning bright light therapy,2 subjects
attempted suicide and the third patient developed suici-
dal thoughts that were so acute and overwhelming that
the light therapy had to be discontinued. In a patient
with rapid-cycling bipolar illness, Wirz-Justice et al
103
found that extending the dark/rest period to 14 h (plus
a 1-h midday nap) immediately stopped the rapid cycling
and when midday, then morning light therapy was
added, depression gradually improved achieving near-
euthymia. In 115 bipolar depressed inpatients treated
with total sleep deprivation,
104 morning light therapy
(150 or 2500 lux) and ongoing lithium treatment signif-
icantly enhanced and sustained the effects of total sleep
deprivation on mood, with no additional benefit when
the two treatments were combined.
Women’s mood disorders
The efficacy of light treatment has been studied in
women with premenstrual (late luteal phase) dysphoric
disorder.
105-108 In an open trial of morning light therapy for
treatment of antepartum depression, Oren et al
109
observed that,after 3 weeks of treatment,mean depres-
sion ratings improved by 49%. Benefits were seen
through 5 weeks of treatment and there was no evidence
of adverse effects of light therapy on pregnancy.In two
patients with postpartum depression,
110 there was a 75%
reduction in depressive symptoms with light therapy.
In summary,the emerging evidence suggests the poten-
tial efficacy of light treatment in MDD,in inpatients and
outpatients,and in women’s mood disorders.Light treat-
ment may also enhance the efficacy of other antidepres-
sant modalities.
Proposed mechanisms
Circadian timing
Lewy et al
111 proposed that the timing of bright light is crit-
ical for its antidepressant effect in SAD:the mechanism
was related to a phase-advance of circadian rhythms that
corrected a pathogenic phase-delay.Terman et al
112 found
that the antidepressant effect of light in SAD was poten-
tiated by early-morning administration in circadian time,
optimally about 8.5 h after melatonin onset or 2.5 h after
the sleep midpoint, suggesting the importance of phase
relationships in treatment response.
Melatonin
Terman et al
113 proposed that early morning and evening
light exposure impacted a photosensitive interval in
SAD patients, in which melatonin secretion overshoots
its normal nocturnal phase. Despite equal suppression
of plasma melatonin levels,altered timing of light treat-
ments has differential effects on mood.
114 Danilenko et
al
115 found that daytime (12 noon and 4.00 PM) serum
melatonin levels were higher in women with SAD com-
pared with controls in winter; this difference disap-
peared in the summer and after light treatment in the
winter. Light treatment and change in season also
resulted in a phase-advance shift of melatonin in the
SAD patients,associated with a decline in symptoms of
hyperphagia and carbohydrate craving. Partonen
116
hypothesized that the induction of arousing stimuli
mediated by effects of melatonin and the blockade of
serotonin uptake mechanisms in the suprachiasmatic
nucleus is necessary for the antidepressant effects of
light in SAD.In patients with SAD who underwent light
treatment with full-spectrum or cool white light,
117 both
treatments reduced depression scores,advanced the tim-
ing of the salivary melatonin rhythm (in both responders
and nonresponders),and increased its concentration.In
light treatment of patients with seasonal and nonsea-
sonal depression,melatonin amplitude was decreased by
light and its phase position was advanced by morning
light and delayed by evening light, but therapeutic out-
come was not related to baseline melatonin phase posi-
tion,the degree of light suppression of melatonin or the
rebound effect of serum melatonin levels following
bright light exposure.
118
Serotonin
A study of patients with nonseasonal depression and
healthy subjects
119,120 found that both bright as well as
dim light augmented blood serotonin throughout the
day. The influence of light was more pronounced on
serotonin than on melatonin metabolism. Mellerup et
al
121 examined platelet paroxetine binding as an indirect
measure of the effect of light therapy on serotonin
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found that in responders, but not in nonresponders,
platelet serotonin transporters decreased significantly
following treatment.An extended study of the seroton-
ergic agent meta-chlorophenylpiperazine (m-CPP)
122
replicated the finding that m-CPP–induced activation-
euphoria responses in untreated depressed patients with
SAD,reflecting a state marker for the illness.This study
also showed blunted corticotropin and norepinephrine
responses to m-CPP, suggesting trait abnormalities.
Mood improvement after light treatment was associated
with lowering of nocturnal core temperatures, compat-
ible with deficient serotonin transmission during winter
depression.In a study of platelet serotonergic functions
in SAD, Stain-Malmgren et al
123 found that responders
to light therapy had higher Km and lower Bmax for parox-
etine binding than nonresponders, suggesting abnor-
malities in the serotonin uptake mechanism with
enhanced serotonin 5-HT2 receptor density that may
reflect an upregulation.
Effects of tryptophan depletion
Rapid tryptophan depletion reverses the antidepressant
effect of bright light therapy in patients with SAD,
124,125
suggesting that the therapeutic effects of bright light in
this disorder may involve a serotonergic mechanism.
Neumeister et al
126 also demonstrated that catecholamine
depletion reversed the beneficial effects of light therapy,
suggesting that brain catecholaminergic systems may also
be involved.
Other neurotransmitters
In studies of platelet [
3H]imipramine binding in patients
with or without SAD,and healthy controls,Szadoczky et
al
127,128 observed that,after incandescent light treatment,
Bmax values increased in SAD patients parallel with clin-
ical improvement. In patients with SAD, light therapy
produced a decrease in the urinary output of norepi-
nephrine and its metabolites in association with signifi-
cant decreases in depression ratings.
129 In contrast,
Rudorfer et al
130 measured cerebrospinal fluid concen-
trations of the principal metabolites of norepinephrine,
serotonin, and dopamine and did not find differences
between SAD and healthy controls.Neither the trans-
mitter measures nor their interrelatedness was affected
by phototherapy.
Endocrine function
On the basis of observed low serum prolactin concentra-
tion in women with winter depression that was indepen-
dent of season and bright light treatment, Partonen
131
hypothesized a role for estrogen and serotonergic func-
tion in SAD.Normal thyroid function in SAD does not
alter with light treatment.
132 Serum cortisol does not dif-
fer between SAD and non-SAD patients,and no signifi-
cant changes were seen as a result of light treatment,
although melatonin appears to serve as a coordinating
hormone transducing light information for the phase posi-
tion of cortisol.
133 Partonen
134 also hypothesized that bright
light,by normalizing increased corticotropin-releasing fac-
tor (CRF) activity in the evening in SAD,might thereby
normalize subjective sleepiness via its effects on neurons
of the paraventricular nucleus of the hypothalamus. In
studies of growth hormone (GH),Yatham et al
135 reported
that GH responses to sumatriptan (a 5-HT1D receptor
agonist) were significantly blunted during winter depres-
sion in SAD patients compared with healthy controls and
were normalized following light treatment.These findings
suggest a role for the serotonergic system in the mecha-
nism of action of light therapy.In contrast,Shiah et al
136
found that GH response to the γ-aminobutyric acid
(GABA)B receptor agonist,baclofen,was not altered in
SAD or by light therapy. On the basis of evidence that
heme moieties and bile pigments in plants and animals
mediate some of the nonvisual influences of light on bio-
logical rhythms,Oren
137 hypothesized that bilirubin,which
is a proposed photoreceptor given its similarity to the
chromophore of phytochrome (a primary time-setting
plant molecule),plays an evolutionary role in the regula-
tion of rapid-eye movement (REM) sleep and in mediat-
ing some of the antidepressant effects of light.He and his
colleagues
138 found that nocturnal bilirubin levels were
lower in patients with winter depression compared with
controls,and that levels increased in both groups during
the night and increased in patients after 2 weeks of morn-
ing light treatment that improved mood.
Sleep, hemispheric, and EEG changes
Bright light shortens sleep onset, decreases number of
awakenings, increases REM latency, attenuates REM
length,and improves morning alertness in patients with
MDD.
139 In SAD patients, Partonen et al
140 found no
sleep electroencephalographic (EEG) changes after
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was reduced.SAD patients have the expected pattern of
EEG frontal asymmetry when depressed and following
light-induced remission, although right hemisphere
coherence is a state-dependent indicator of seasonal
depression.
141Winter depression is associated with a shift
of laterality from the left to the right that was normal-
ized by bright light treatment.
142 Brunner et al
143 docu-
mented normal homeostatic sleep regulation in SAD;
although sleep EEG spectra in SAD, but not controls,
showed modifications resembling those of recovery
sleep after light treatment (perhaps reflecting sleep cur-
tailment),the authors concluded that the effects of light
treatment in SAD were unlikely to be mediated by
changes in sleep.A positive response to total sleep depri-
vation in major depression is predictive of a beneficial
outcome of subsequent light therapy.
144
Temperature regulation
In a review of the neurobiological effects of artificial
bright light,Dilsaver
145 reported that,based on measures
of core temperature,bright light subsensitizes muscarinic
and nicotinic mechanisms.Although temperature curves
between SAD and controls were similar,light treatment
enhanced the amplitude of the core body temperature
rhythm in SAD patients during winter.
146There were no
abnormalities in the baseline phase or amplitude of the
temperature rhythm in SAD patients versus controls,
147
and antidepressant responses to light treatment were
unrelated to changes in the temperature rhythm.In con-
stant routine conditions, Avery et al
148 documented a
phase-delay of temperature and cortisol rhythms in
hypersomnic winter depression that phase-advanced with
bright light treatment.Schwartz et al
149 observed that core
temperature minima were lower during the extended
photoperiod of summer compared with winter in SAD
patients,but not controls.In studying the oscillations of
facial skin and core temperatures in relation to slow-
wave activity during sleep, Schwartz et al
150 found that
brain cooling activity, which oscillates in an ultradian
manner during sleep, is reduced during winter depres-
sion,providing support for the hypothesis that brain tem-
peratures are elevated during winter depression.
Functional anatomic and retinal sensitivity factors
Seggie et al
151 observed that antidepressant medication
(sinuequan) reversed the increased sensitivity to light in
depression.Terman and Terman
152 reported heightened
retinal sensitivity with increased light exposure and
supersensitivity of SAD patients relative to controls in
winter. UVA-spectrum light did not increase the anti-
depressant response
153 and illumination applied in the
upper visual field was most effective.
154 An increase in
cerebral blood flow is associated with recovery follow-
ing light treatment for SAD.
155
Other
Patients with non-SAD major depression show a more
pronounced light-associated increment of parasympa-
thetically controlled cardiac functions compared with
other depressed patients and controls.
156 Light therapy
normalizes transducin (G1 protein) levels observed to be
reduced in winter depression.
157 No effects of light ther-
apy were noted on basal glucagon levels in SAD and
comparison subjects.
158 Immune-inflammatory markers
are increased in SAD patients but are not altered by suc-
cessful light therapy.
159
In summary,the proposed mechanisms for light treatment
primarily involve effects on the circadian timing system,
melatonin,serotonin,and temperature regulation.
Conclusions
Light treatment is efficacious for SAD (winter-type) and
an increasing database suggests that it has beneficial effects
in nonseasonal depression as well. In toto, bright light
(>2500 lux) results in greater improvement than dim light;
morning light of at least 3 to 4 days duration results in
more responders than evening light in SAD;UV-spectrum
wavelengths are not required for antidepressant effects;
and dawn-stimulation is an effective alternative. Light
visors,in contrast,are not efficacious.Carbohydrate crav-
ing is a predictor of response and there are minimal side
effects with the exception of the risk of inducing mania in
bipolar patients.Further investigation is warranted with
respect to light treatment’s mechanism of action. ❏
Light treatment of mood disorders - Parry and Maurer Dialogues in Clinical Neuroscience - Vol 5 . No.4 . 2003
361Pharmacological aspects
362
Fototerapia de los trastornos afectivos
En 1981 siete pacientes con depresión no estacional
fueron tratados con luz blanca brillante. En 1982 se
utilizó luz artificial brillante para tratar a un paciente
maníaco-depresivo con un ciclo de ánimo estacional.
En los últimos 20 años gran cantidad de estudios han
permitido definir con mayor precisión, además de las
poblaciones de pacientes depresivos que responden
a la fototerapia, el momento óptimo de la aplica-
ción, la intensidad, la frecuencia del espectro y la
duración del tratamiento. También se la ha compa-
rado con otras intervenciones farmacológicas, se han
estudiado los predictores de respuesta, el perfil de
efectos colaterales, el uso de placebos adecuados a
estos estudios, diversos aparatos y formas de admi-
nistración, potenciales mecanismos y vías anatómi-
cas que median los efectos farmacológicos de la luz
y su aplicación a otros trastornos y estados subsin-
dromáticos. Estos estudios se han realizado en varios
países con resultados sorprendentemente constan-
tes. Se requiere de futuros trabajos, como se destaca
en esta revisión, para aclarar el mecanismo de acción
específico en subtipos de trastornos depresivos y
diferenciar efectos según edad y sexo. Aunque la
mayor parte del trabajo en esta área es relativa-
mente nuevo, le corresponde al lector recordar que
Salomón, hace casi 3000 años, escribió en el
Eclesiastés (11:7) “Verdaderamente la luz es dulce y
es algo placentero para los ojos contemplar el sol.”
Luminothérapie des troubles de l’humeur
En 1981, sept patients atteints de dépression non sai-
sonnière ont été traités par lumière blanche intense.
En 1982, la lumière artificielle intense a été utilisée
pour traiter un patient maniacodépressif souffrant
d’un trouble cyclothymique saisonnier. Durant ces 20
dernières  années, une pléthore d’études ont mieux
identifié les populations dépressives sensibles à la
luminothérapie ; le rythme optimal du traitement,
son intensité, sa fréquence spectrale et sa durée ; 
sa comparaison avec d’autres types de traitement ;
les facteurs prédictifs de réponse ; les effets secon-
daires ; les conditions placebo/témoin adaptées ; les
techniques alternatives et les différentes méthodes
d’administration ; les voies anatomiques et les méca-
nismes potentiels véhiculant les effets physiologiques
de la lumière ; et ses applications aux autres troubles
et états sous-syndromiques. Ces études ont été
conduites dans de nombreux pays, la concordance
des résultats étant tout à fait surprenante. Comme
le souligne cet article, d’autres travaux sont néces-
saires afin de clarifier les mécanismes d’action spéci-
fiques dans les sous-types de troubles dépressifs et
l’influence de l’âge et du sexe. Bien que la majorité
des travaux dans ce domaine soit relativement
récente, il incombe au lecteur de se souvenir de ce
que Salomon, il y a presque 3 000 ans, écrivit dans
l’Ecclésiaste (XI, 7) : « Douce est la lumière et il plaît
aux yeux de voir le soleil ».
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